2-amino-5-phosphonovalerate has been researched along with Hamartoma in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Xu, L | 1 |
| Kim, DY | 1 |
| Rho, JM | 1 |
| St John, PA | 1 |
| Lue, LF | 1 |
| Coons, S | 1 |
| Ellsworth, K | 1 |
| Nowak, L | 1 |
| Johnson, E | 1 |
| Rekate, H | 1 |
| Kerrigan, JF | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Hamartoma
| Article | Year |
|---|---|
Electrophysiological properties of human hypothalamic hamartomas.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adolescent; Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolep | 2005 |